NPC
CYTR

National Planning Corporation’s CytRx Corp CYTR Stock Holding History

National Planning Corporation’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-48
Closed -$970 – 2700
2014
Q4 		$970 Buy
+48
New +$749 ﹤0.01% 2689

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

National Planning Corporation's CYTR Position: Q1 2015 in Review

National Planning Corporation sold out of CytRx Corp (CYTR) in Q1 2015, closing a stake of 48 shares — an estimated $970 sold.

National Planning Corporation first reported a position in CYTR in Q4 2014 and held it in 1 quarter. The position peaked at $970 in Q4 2014. 64 funds tracked by Wall St. Rank hold CYTR as of Q1 2015.

  • National Planning Corporation reported no remaining CytRx Corp position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 48 CytRx Corp shares in Q1 2015, an estimated $970.
  • National Planning Corporation first reported a position in CytRx Corp in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's CytRx Corp position peaked at $970 in Q4 2014.
  • 64 funds tracked by Wall St. Rank held CytRx Corp as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.